Exclusive

Publication

Byline

Location

US Patent Issued to CHIESI FARMACEUTICI on April 21 for "Pyridopyrimidines derivatives as P2X3 inhibitors" (Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,562, issued on April 21, was assigned to CHIESI FARMACEUTICI S.P.A. (Parma, Italy). "Pyridopyrimidines derivatives as P2X3 inhibitors" was... Read More


US Patent Issued to LG CHEM on April 21 for "Organic light-emitting device" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,563, issued on April 21, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Organic light-emitting device" was invented by Dong Uk Heo (D... Read More


US Patent Issued to ILDONG PHARMACEUTICAL on April 21 for "Adenosine receptor antagonist compounds" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,564, issued on April 21, was assigned to ILDONG PHARMACEUTICAL Co. LTD. (Seoul, South Korea). "Adenosine receptor antagonist compounds" wa... Read More


US Patent Issued to PYRAMID BIOSCIENCES on April 21 for "Methods for preparing tyrosine receptor kinase inhibitors" (Indian, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,565, issued on April 21, was assigned to PYRAMID BIOSCIENCES INC. (Waltham, Mass.). "Methods for preparing tyrosine receptor kinase inhibi... Read More


US Patent Issued to SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES, ZHEJIANG HUAHAI PHARMACEUTICAL on April 21 for "Substituted cyclopenta[4,5pyrrolo[1,2-apyrazines as bruton's tyrosine kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,566, issued on April 21, was assigned to SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES Co. LTD. (Shanghai) and ZHEJIANG HUAHAI PHARMACEUTICAL Co... Read More


US Patent Issued to Recurium IP Holdings on April 21 for "Salts and forms of a WEE1 inhibitor" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,567, issued on April 21, was assigned to Recurium IP Holdings LLC (San Diego). "Salts and forms of a WEE1 inhibitor" was invented by Chad ... Read More


US Patent Issued to Kymera Therapeutics on April 21 for "SMARCA degraders and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,568, issued on April 21, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.). "SMARCA degraders and uses thereof" was invented by ... Read More


US Patent Issued to Biotelliga Holdings on April 21 for "Alkaloid-containing compositions and uses thereof" (New Zealander Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,569, issued on April 21, was assigned to Biotelliga Holdings Ltd. (Auckland, New Zealand). "Alkaloid-containing compositions and uses ther... Read More


US Patent Issued to CHDI Foundation on April 21 for "Deuterated compounds and imaging agents for imaging huntingtin protein" (American, British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,570, issued on April 21, was assigned to CHDI Foundation Inc. (New York). "Deuterated compounds and imaging agents for imaging huntingtin ... Read More


US Patent Issued to Turning Point Therapeutics on April 21 for "Macrocyclic compounds and uses thereof" (North Carolina, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,571, issued on April 21, was assigned to Turning Point Therapeutics Inc. (Princeton, N.J.). "Macrocyclic compounds and uses thereof" was i... Read More